Durability of HBeAg Seroconversion After Treatment with Entecavir or Tenofovir in Chronic Hepatitis B Patients

被引：0
|
作者：
Fong, Tse-Ling [1 ,2 ]
Mena, Edward A. [3 ]
Yu, Andy S.
Quang-Quoc Phan
Han, Steven-Huy B. [4 ]
Tien, Andy [1 ]
Velasco, Andrew J. [1 ]
Leduc, Vinh-Huy [1 ]
Tong, Myron J. [3 ,4 ]
机构：
[1] St Vincents Med Ctr, Asian Pacific Liver Ctr, Los Angeles, CA USA
[2] Univ So Calif, Los Angeles, CA USA
[3] Huntington Med Res Inst, Pasadena, CA USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1912
引用
收藏
页码：1121A / 1122A
页数：2
相关论文
共 50 条
  • [31] Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNA
    Shi, Hong
    Huang, Mingxing
    Lin, Guoli
    Li, Xiangyong
    Wu, Yuankai
    Jie, Yusheng
    Chong, Yutian
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [32] Chronic Hepatitis B: Tenofovir and Entecavir compared
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (09):
  • [33] Durability of HBeAg seroconversion in chronic hepatitis B patients after lamivudine A-interferon or lamivudine A- interferon combination therapy
    Van Nunen, AB
    Hansen, B
    Suh, D
    Loehr, H
    Fontaine, H
    Chemello, L
    Song, B
    Heathcote, J
    Janssen, H
    de Man, RA
    Schalm, SW
    JOURNAL OF HEPATOLOGY, 2001, 34 : 155 - 155
  • [34] Hepatitis B Seroconversion After Rituximab Treatment and Seroclearance After Tenofovir Treatment
    Vyas, Aditya
    Khan, Mohammad Hassaan
    Pandit, Sudha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1166 - S1167
  • [35] Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients
    Kara, A., V
    Yildirim, Y.
    Ozcicek, F.
    Aldemir, M. N.
    Arslan, Y.
    Bayan, K.
    Celen, M. K.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2019, 82 (02) : 273 - 277
  • [36] INFLUENCE OF HEPATIC STEATOSIS ON THE TREATMENT OUTCOMES OF ENTECAVIR AND TENOFOVIR IN PATIENTS WITH CHRONIC HEPATITIS B
    Jeon, Mi Young
    Kim, Seung Up
    Kim, David S.
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    GUT, 2018, 67 : A90 - A90
  • [37] OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDERGOING ENTECAVIR OR TENOFOVIR TREATMENT
    Lee, Chieh-Ju
    Su, Chien-Wei
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    HEPATOLOGY, 2019, 70 : 578A - 579A
  • [38] On-treatment HBV RNA dynamic predicts entecavir-induced HBeAg seroconversion in children with chronic hepatitis B
    Wu, Yongbin
    Wen, Jian
    Tang, Guifang
    Zhang, Jing
    Xin, Jie
    JOURNAL OF INFECTION, 2021, 83 (05) : 594 - 600
  • [39] Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatment
    Zhao, Xiang-An
    Wang, Jian
    Liu, Jiacheng
    Chen, Guangmei
    Yan, Xiaomin
    Jia, Bei
    Yang, Yue
    Liu, Yong
    Gu, Da
    Zhang, Zhaoping
    Xiang, Xiaoxing
    Huang, Rui
    Wu, Chao
    ANTIVIRAL RESEARCH, 2021, 193
  • [40] Durability of virological response in HBeAg-positive chronic hepatitis B patients achieving HBeAg seroconversion during nucleos(t)ide analogue treatment
    Wilson, J. L.
    Thompson, A. J. V.
    Bell, S. J.
    Demediuk, B.
    Shaw, G.
    Watson, K. J. R.
    Desmond, P. V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A306 - A306
12345